Allergy & Immunology CME

Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
New Frontiers in Precision Immuno-Oncology: Leveraging Biomarkers to Refine and Expand the Use of Cancer Immunotherapies and Combinations
Justin Gainor, MD
26 April, 2019
Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
Addressing Unmet Needs in Earlier Stages of NSCLC With Immunotherapy: Cutting-Edge Research, Clinical Applications, and Practical Challenges
Scott Antonia, MD, PhD
15 April, 2019
Credits: 0.75 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Advances in the Management of Allergic and Inflammatory Diseases: Highlights From Washington, DC and San Francisco
Jonathan Corren, MD / Paul Yamauchi, MD
12 April, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Harnessing Recent Advances in CAR-T Cell Therapy for Leukemia and Lymphoma in the Era of Stem Cell Transplantation
Tanya Siddiqi, MD / Shannon L. Maude, MD, PhD
2 April, 2019
Credits: 1.00 CME / MOC / CNE
Medical Learning Institute, Inc.
Rheumatology, Immunology, and Immuno-Oncology Intersect: Navigating the Complexities of Immune Checkpoint Inhibition, Autoimmunity, and Immune-Related Adverse Events
Leonard Calabrese, DO
29 March, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Innovative Therapies in Post-Transplant GVHD: Personal Insights From the Patient CaseBook
Madan Jagasia, MBBS, MS, MMHC
28 March, 2019
Credits: 1.00 CME / MOC / CNE
Medical Learning Institute, Inc.
Expanding Options and Difficult Choices in the Initial Treatment of Advanced NSCLC: How to Personalize Treatment Decisions in the Era of Immuno-Oncology and Combinations
Mark Socinski, MD
27 March, 2019
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Urgent Care of Patients Receiving Cancer Immunotherapy: Recognition and Management of Immune-Mediated Adverse Reactions in the ED
Evan Lipson, MD
22 February, 2019
Credits: 1.50 CME
Medical Learning Institute, Inc.
Breaking the Paradox: Expanding Options and New Questions in HCC Management—Mapping the Pathways to Better Patient Outcomes
Richard Finn, MD
15 February, 2019
Credits: 1.00 CME
Medical Learning Institute, Inc.
Keeping Pace With Immunotherapy Advances in Bladder Cancer: Tools for Winning the Race and Optimizing Patient Outcomes
Arjun Balar, MD
31 December, 2018
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
The Central Role of Biomarker Testing in Piecing Together the Immuno-Oncology Puzzle: Essential Guidance for Pathologists to Maximize the Potential of Cancer Immunotherapies
Robert Anders, MD, PhD
27 December, 2018
Credits: 1.50 CME / MOC / CE / CPE
Medical Learning Institute, Inc.
Incorporating Cancer Immunotherapies Into the Oncology Treatment Arsenal in Managed Care Settings: Navigating the Complexities of Value Assessment & Cost Optimization in the Era of Immuno-Oncology
Michael Atkins, MD
24 December, 2018
Credits: 1.00 CME / MOC / CE
Medical Learning Institute, Inc.
The Evolving Role of Immunotherapy as a Component of Multimodal Therapy in Earlier Stages of Lung Cancer: Rationale, Current Evidence, Key Trials, and Implications for Multidisciplinary Care
Naiyer Rizvi, MD
14 December, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
The Era of Immunotherapy in Stage III NSCLC: Exploring the Evidence and Practicalities of Integrating Checkpoint Inhibition Into the Multimodal Treatment Arsenal
Roy Decker, MD, PhD
7 December, 2018
Credits: 1.00 MOC / CME
Medical Learning Institute, Inc.
Advances and Challenges in Refining the Use of Cancer Immunotherapies Through Biomarker Testing: Practical Guidance for Pathologists on the Front Lines of the Immuno-Oncology Revolution
Kurt Schalper, MD, PhD / Edward B. Garon, MD, MS
30 November, 2018
Credits: 1.50 CME / MOC / CE
Medical Learning Institute, Inc.
Improving Patient Outcomes With Cancer Immunotherapies Throughout the Lung Cancer Continuum: State of the Science and Implications for Practice
Edward Garon, MD, MS
22 November, 2018
Credits: 1.50 CME / MOC / CE
Medical Learning Institute, Inc.
Emergency Medicine and Immuno-Oncology Intersect: Recognizing and Managing Cancer Immunotherapy–Related Adverse Effects in the Emergency Department
Daniel Pallin, MD, MPH
21 November, 2018
Credits: 1.00 CME
Medical Learning Institute, Inc.
A MasterClass on New Avenues in Asthma Management: Finding the Right Patients for Targeted Therapies
Jonathan Corren, MD
7 November, 2018
Credits: 0.25 CME
Penn State College of Medicine
Advances in the Management of Inflammatory Bowel Disease: Clinical Highlights From Washington, DC
David Rubin, MD
22 August, 2018
Credits: 0.50 CME
Medical Learning Institute, Inc.
Progressive Fibrosing Interstitial Lung Disease: Shining a Light on the Latest Clinical Advances
Kevin Flaherty, MD, MS
13 August, 2018
Credits: 0.50 CME
Medical Learning Institute, Inc.
Exploring the Latest Data in the Treatment of Uncontrolled Persistent Asthma: Clinical Highlights From San Diego
Nicola Hanania, MD, MS
13 July, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
Tracing the Arc of Immunotherapy in Melanoma: Insights on the Current Role and Cutting-Edge Uses of Checkpoint Inhibitors for Patient Care
Omid Hamid, MD
11 July, 2018
Credits: 2.00 CME
Medical Learning Institute, Inc.
Realizing the Potential of Precision Oncology in Lung Cancer—Challenges and Opportunities: Strengthening the Partnership Between Oncology and Pathology to Make the Most of the Latest Diagnostics and Therapies
Edward Garon, MD, MS
5 July, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
The Advent of Immunotherapy in Gastrointestinal Cancers: MasterClass and Practicum on Checkpoint Inhibition and Biomarkers in Colorectal and Gastric Tumors
Prof Eric Van Cutsem, MD, PhD
3 July, 2018
Credits: 1.50 MOC / CME / CE / CPE
Medical Learning Institute, Inc.
Navigating the Expanding Sphingosine-1-Phosphate Receptor Modulator Armamentarium for Multiple Sclerosis Management: Greater Opportunities for Patients With MS
Bruce Cree, MD, PhD, MAS
29 June, 2018